ICT01

· ImCheck Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ICT01, covering 2025-12-24 to 2026-01-27. Get the full timeline:

Most recent: Clinical Trial Update: First-in-Human Study of ICT01 in Patients With Advanced Cancer [Phase 1, Phase 2]